Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Formerly called dysembryoplastic neuroepithelial tumour (DNET) of the septum pellucidum, myxoid glioneuronal tumour (MGT) was recently recognized as a distinct entity. We report three cases of presumed MGT with typical location and image features.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749391 | PMC |
| http://dx.doi.org/10.1259/bjrcr.20200139 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Are Dinucleotide Alterations Definitional for Myxoid Glioneuronal Tumor? Report of p. K385L Mutation in a Neonatal High-Grade Glioma.
Pediatr Dev Pathol
March 2025
Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Tumors are increasingly defined by molecular alterations but approach to cases with discordant histologic and molecular features is unclear. Myxoid glioneuronal tumor (MGNT), histologically similar to dysembryoplastic neuroepithelial tumor (DNET), is characterized by dinucleotide mutations in gene (K385L or K385I). Here, we report K385L mutation in a neonatal high-grade glioma.
View Article and Find Full Text PDFMyxoid glioneuronal tumor of the septum pellucidum in pediatric patients: a case report and comprehensive review of the literature.
Childs Nerv Syst
November 2024
Department of Pathology, Cukurova University School of Medicine, Adana, Turkey.
Introduction: Myxoid glioneuronal tumor of the septum pellucidum is an uncommon clinical entity, previously referred to dysembryoplastic neuroepithelial tumor located in the septum pellucidum.
Methods: This study was conducted following PRISMA guidelines. A comprehensive literature search was performed in the PubMed/MEDLINE, Web of Science, and Scopus databases.
Imaging of pediatric glioneuronal and neuronal tumors.
Childs Nerv Syst
October 2024
Division of Neuroradiology, Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, 170 Elizabeth Street, Toronto, ON, M5G 1E8, Canada.
Glioneuronal tumors (GNTs) are an expanding group of primary CNS neoplasms, commonly affecting children, adolescents and young adults. Most GNTs are relatively indolent, low-grade, WHO grade I lesions. In the pediatric age group, GNTs have their epicenter in the cerebral cortex and present with seizures.
View Article and Find Full Text PDFEnrichment of oligodendrocyte precursor phenotypes in subsets of low-grade glioneuronal tumours.
Brain Commun
May 2024
Department of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
Current histological classification of low-grade glioneuronal tumours does not adequately represent their underlying biology. The neural lineage(s) and differentiation stage(s) involved and the cell state(s) affected by the recurrent genomic alterations are unclear. Here, we describe dysregulated oligodendrocyte lineage developmental programmes in three low-grade glioneuronal tumour subtypes.
View Article and Find Full Text PDFOne case of myxoid glioneuronal tumour in the left frontal lobe.
BJR Case Rep
May 2024
Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.
Article Synopsis
- Myxoid glioneuronal tumour (MGNT) is a newly classified type of tumor recognized in the 2021 WHO Central Nervous System Tumor Classification, previously known as dysembryoplastic neuroepithelial tumour of the septum pellucidum.
- The classification is based on several factors including the tumor's location, imaging characteristics, and genetic traits.
- This report discusses a specific case of MGNT found in the left frontal lobe, which was verified through surgical pathology methods.